AKT1 and cancer: In this process, the activation status of several cancer-related pathways are changed, including Ras, Wnt/β-catenin, PI3K/AKT, and MAPK signaling pathways (Jones and Baylin, 2007; Ying and Tao, 2009; Fattahi et al., 2020).